Pharm-Synthesis

Pharm-Synthesis is a prominent Russian pharmaceutical company focused on the development, manufacture, and marketing of innovative drugs and active pharmaceutical ingredients. Established in 1997 and headquartered in Moscow, the company specializes in complex therapeutic areas including oncology, gynecology, urology, and neurology. Pharm-Synthesis is particularly noted for its expertise in peptide synthesis and the production of radiopharmaceuticals for diagnostic use. The company operates a state-of-the-art manufacturing facility in the Kaluga region that complies with international Good Manufacturing Practice (GMP) standards. Its product portfolio features both original proprietary medications and high-tech generic versions of essential therapies, such as treatments for prostate cancer and multiple sclerosis.